NEW YORK, Dec. 1, 2023 — Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage […]
Month: December 2023
Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024
TALLAHASSEE, Fla., Dec. 1, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the […]
Fathom Holdings Prices Underwritten Public Offering of Common Stock
CARY, N.C., Dec. 1, 2023 — Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or the “Company”), […]
Kazia Therapeutics Announces $2 Million Registered Direct Offering
SYDNEY, Dec. 1, 2023 — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or the “Company”), an […]